ArticleInternal medicine (Tokyo, Japan)2025

Correlation between Efficacy and Cardiovascular Adverse Events in Patients with Advanced Solid Cancer Who Received VEGF Pathway Inhibitors: Hypertension within the First Eight Weeks Is Associated with Favorable Outcomes of Patients Treated with VEGF Pathway Inhibitors.

Yuya Yoshida et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.